…Introduction Autism spectrum disorder (ASD) is one of the most prevalent neurodevelopmental disorders…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 446 of 2459…s with T1D is more common than in healthy individuals. Men with T1D are more likely to report difficulty achieving orgasm and decre…
…Kidney transplantation (KT) is the preferred treatment for end-stage renal disease, yet post-transplant complications and graft dysfunction remain…
…nd is a novel non-invasive technique for detecting leg anterior chronic exertional compartment syndrome with promising diagnostic accuracy, particularly in males.Trial…
…acting injectable olanzapine (OLAI) is prescribed to stabilised schizophrenia patients previously treated with oral olanzapine to enhance the…
….060 5.16 ± 0.012 Abstract 3PC-005 Tabel 3Average osmolality of atropine sulfate eye dropsBatch 4-week in use (mosm/kgH2O) 14-week stability (mo…
…e solution 600 mg/6 mL. Sterile amber glass. Expiration: 9 days.Acetylcysteine 10% eye drop formulation at Complejo Hospitalario Universitario…
…s evolved with the emergence of new therapeutic targets such as risankizumab. Plasma drug concentrations complement data directly related to…
… critical role in detecting and preventing DRPs. Earlier at the Universitair Ziekenhuis Brussel (UZ Brussel) in 2023 a validation was developed to detect DRPs …
… reaching therapeutic range, except for one discontinuation.For isavuconazole, median concentration was 2.08 (1.59-3.04) µg/mL, 86.7% (13) wi…
…criptions. These findings support the need for gender-sensitive asthma management and further prospective studies.Conflict of Interest…